Claravis | Isotretinoin Capsule Breastfeeding
Modern medicine has evolved so much so that sooner or later every breastfeeding mother needs to take it in one form or other. Medication that is present in mothers blood will transfer into her breast milk to some extent. Most drugs do so at low levels and pose no real risk to infants but then there are some exceptions. In This post will discuss whether Claravis | Isotretinoin Capsule is safe in breast-feeding or not.

What is Claravis | Isotretinoin Capsule used for?


Severe Recalcitrant Nodular Acne Claravis (isotretinoin capsules, USP) is indicated for the treatment of severe recalcitrant nodular acne. Nodules are inflammatory lesions with a diameter of 5 mm or greater. The nodules may become suppurative or hemorrhagic. “Severe,” by definition,2 means “many” as opposed to “few or several” nodules. Because of significant adverse effects associated with its use, Claravis should be reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics. In addition, Claravis is indicated only for those female patients who are not pregnant, because Claravis can cause severe birth defects (see Boxed CONTRAINDICATIONS AND WARNINGS ). A single course of therapy for 15 to 20 weeks has been shown to result in complete and prolonged remission of disease in many patients.1,3,4 If a second course of therapy is needed, it should not be initiated until at least 8 weeks after completion of the first course, because experience has shown that patients may continue to improve while off Claravis. The optimal interval before retreatment has not been defined for patients who have not completed skeletal growth (see WARNINGS, Skeletal, Bone Mineral Density, Hyperostosis, and Premature Epiphyseal Closure).

Claravis | Isotretinoin Capsule while breastfeeding safe or not? Can there be any side effects for infant while using it during breastfeeding?

Claravis | Isotretinoin Capsule high risk while breastfeeding
As Claravis | Isotretinoin Capsule is made of only Isotretinoin, and Isotretinoin is unsafe to use in breastfeeding we can safely reach on conclusion that Claravis | Isotretinoin Capsule is also unsafe to use while breastfeeding. Below is detailed analysis of Isotretinoin and Claravis | Isotretinoin Capsule during location. We recommend you to go through provided detailed analysis as below take decision accordingly. We also recommend you talk to your health care provider before making final decision.

Statement of Manufacturer/Labeler about breastfeeding usage
Nursing Mothers It is not known whether this drug is excreted in human milk. Because of the potential for adverse effects, nursing mothers should not receive Claravis.

Claravis | Isotretinoin Capsule Breastfeeding Analsys


Isotretinoin while Breastfeeding

Unsafe

CAS Number: 4759-48-2

Retinoid which is a synthetic derivative of vitamin A. It is a cis-configuration of Tretinoin, an acid form of vitamin A.Indicated in the treatment of severe forms of acne. At latest update no published data on excretion into breast milk were found. Despite of a high plasma protein-binding capacity, it is a highly lipophilic substance, hence, it is presumed to accumulate in breastmilk. The natural form of vitamin A is readily excreted into breastmilk. In addition to being a potent teratogen (Shirazi 2015), which affects pregnancy, it has been shown to decrease all pituitary hormones levels (Karadag 2011 and 2015) along with other potential serious side effects associated to the use of Isotretinoin. It may cause galactorrhea (Larsen 1985). A safer alternative should be preferred until more published data on this drug related to breastfeeding is available, especially during the neonatal period and in case of prematurity.

Claravis | Isotretinoin Capsule Breastfeeding Analsys - 2


Isotretinoin while Breastfeeding

CAS Number: 4759-48-2

No information is available on the use of isotretinoin during breastfeeding. Various topical agents that are less likely to be absorbed by the mother may be preferred during breastfeeding, especially while nursing a newborn or preterm infant.

Claravis | Isotretinoin Capsule and breastfeeding

I am nursing mother and I have already used Claravis | Isotretinoin Capsule, what should I do?

We have already established that Claravis | Isotretinoin Capsule is unsafe in breastfeeding and breastfeeding while using Claravis | Isotretinoin Capsule is not a good idea however if have already used and then breastfed the baby then you shall monitor the behavior and health of baby closely and inform your doctor as soon as possible. In case of emergency please call 911.


I am nursing mother and my doctor has suggested me to use Claravis | Isotretinoin Capsule, is it safe?

If your doctor knows that you are breastfeeding mother and still prescribes Claravis | Isotretinoin Capsule then there must be good reason for that as Claravis | Isotretinoin Capsule is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Claravis | Isotretinoin Capsule, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Claravis | Isotretinoin Capsule and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Claravis | Isotretinoin Capsule in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Absorica | Isotretinoin Capsule